The DOI matches its Crossref record; the references it cites are not checked yet.
Age-specific prevalence and causes of bilateral and unilateral visual impairment in older Australians: the Blue Mountains Eye Study
Abstract
PURPOSE: To report age-specific prevalence and causes of bilateral and unilateral visual impairment in a representative older Australian population. METHODS: Participants in the Blue Mountains Eye Study (n = 3654) underwent a detailed eye examination. Any visual impairment was defined as best-corrected visual acuity (VA) of 6/12 or worse, moderate impairment as VA 6/24-6/60 and severe impairment as VA worse than 6/60 (the Australian definition for legal blindness). Bilateral visual impairment was defined from the better eye and unilateral impairment from the worse eye. Proportional causes for visual loss were determined by the examining ophthalmologist. RESULTS: Prevalence of bilateral and unilateral visual impairment was strongly age related. Corresponding bilateral and unilateral visual impairment prevalence rates were, respectively, 0.6% and 3.6% for persons aged 49-59 years, 1.1% and 8.2% for ages 60-69, 5.4% and 20.1% for ages 70-79, and 26.3% and 52.2% for persons aged 80+ years. Overwhelmingly, age-related maculopathy (ARM) was the predominant cause of bilateral blindness (13/17) and of moderate to severe bilateral visual impairment in persons aged 70+ years. However, cataract was the most frequent cause of mild bilateral visual impairment among persons aged 60+ years. Amblyopia was the most frequent cause of mild or worse unilateral visual impairment in persons aged 49-59 years. Cataract was the most common cause of mild unilateral visual impairment in people aged 60+ years, while ARM and cataract were jointly the most frequent causes of moderate to severe unilateral visual impairment in people aged 70+ years. CONCLUSIONS: These findings indicate that around half of visually impaired persons aged 60 years or over had cataract, a cause amenable to treatment.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The incidence of advanced age-related macular degeneration increases with age, as does the development of large drusen and pigmentary changes.
“These three large population-based studies have found that the incidence of advanced age-related macular degeneration increases with age, as does the development of large drusen and pigmentary changes.”
From Age-related macular degeneration (2008) · cites this paper as [18]
The Blue Mountains Eye Study estimated the overall 5-year incidence of advanced age-related macular degeneration to be 1.1%, increasing from 0% in individuals under 60 years of age to 5.4% in those aged 80 years or older.
“The Blue Mountains Eye Study estimated the overall 5-year incidence of advanced age-related macular degeneration to be 1·1%; increasing from 0% in individuals under 60 years of age to 5·4% in those aged 80 years or older.”
From Age-related macular degeneration (2008) · cites this paper as [18]
The overall 5-year incidence of the development of large drusen or pigmentary changes was 8.7%, ranging from 3.2% in those aged less than 60 years to 18.3% in those aged 70-79 years and 14.8% in those older than 80 years.
“The overall 5-year incidence of the development of large drusen or pigmentary changes was 8·7%, ranging from 3·2% in those aged less than 60 years to 18·3% in those aged 70–79 years and 14·8% in those older than 80 years.17,18”
From Age-related macular degeneration (2008) · cites this paper as [18]
Citations
The citation lists haven’t been fetched yet
References 22 · Cited by 197
Research works printed but not linked: 1
- 10.1016/S0161-6420(95)30846-9 · DOI · Paper page
Metadata
- Authors
- Wang, J. J., Foran, S., & Mitchell, P.
- Affiliations
- The University of Sydney (AU)
- Corresponding author
- Mitchell, Paul
- Venue
- Clinical & Experimental Ophthalmology
- Publisher
- Wiley
- Published
- 2000-08
- Volume
- 28
- Issue
- 4
- Pages
- 268-273
- ISSN
- 1442-6404 (ISSN-L)
- 1442-9071
- OpenAlex
- W1999167969
- Cited by
- 197
- References
- 22
- Citations by year
- 2025: 1 · 2024: 6 · 2023: 4 · 2022: 12 · 2021: 4 · 2020: 5 · 2019: 8 · 2018: 7 · 2017: 8 · 2016: 8 · 2015: 8 · 2014: 9 · 2013: 11 · 2012: 6
- FWCI
- 2.94
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical and Experimental Ophthalmology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Ophthalmology › Ophthalmology and Visual Impairment Studies
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Health Sciences › Medicine › Ophthalmology › Glaucoma and retinal disorders
- Keywords
- visual impairment, age-related maculopathy, cataract, amblyopia, prevalence, older adults, best-corrected visual acuity, legal blindness, Blue Mountains Eye Study
- MeSH terms
- Aged, Aged, 80 and over, Eye Diseases, Female, Humans, Male, Middle Aged, New South Wales, Vision Disorders, Vision Tests, Visual Acuity, Prevalence, Age Distribution, Persons with Visual Disabilities
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review